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High Retention in an FQHC MOUD Program Despite Substantial Vulnerabilities in Population 
Qais Iqbal, BS, Lara Weinstein, MD, MPH, DrPH* 
 
Background: Seventy-thousand people in Philadelphia use heroin, and another 50,000 misuse 
prescription opioids. Philadelphia has increased its capacity for medication for opioid use 
disorder (MOUD) with buprenorphine from 100 slots in 2017 to 2,906 as of December 2018, but 
clearly there is still a need for thousands of more treatment slots. Additionally, recent 
evaluations reveal people from vulnerable populations, including homeless, non-white, and 
those with chronic medical diseases, have compounded difficulty accessing MOUD, even if 
there is sufficient capacity. Our objective was to describe and report initial outcomes of a low-
threshold  MOUD program at our Federally Qualified Health Center (FQHC) in Philadelphia. 
Methods: We followed 79 patients at our FQHC from their time of initiation until their 
unplanned treatment termination. Additionally, the relationship of time retained in treatment 
was compared against homelessness status or cocaine use at baseline through Kaplan-Meier 
Survival estimates. 
Results: 3 month retention: 82%. 6 month retention: 63%. No significant differences in 
treatment retention were found between individuals experiencing homelessness vs. not 
homeless (p=0.25) and cocaine use vs. no cocaine use (p=0.12). 
Conclusions: Our FQHC MOUD Program engaged a high level of marginalized groups facing 
multiple vulnerabilities, and retained them in treatment at rates comparable or higher than 
reported figures from other FQHCs. This shows that the low-threshold, group based model 
integrated into a primary care setting shows promise in increasing access to and retention in 
MOUD services. 
 
